Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04528446 · ClinicalTrials.gov registry record
The Impact of Glomerular Disorders on Bone Quality and Strength
A clinical trial of Glomerular Disease and Bone Fracture, sponsored by Columbia University.
- Recruiting
- Registry status
- 270
- Enrollment target
- 2
- Study locations
NCT04528446: Recruiting study of Glomerular Disease and Bone Fracture, sponsored by Columbia University.
NCT04528446 is a study of Glomerular Disease and Bone Fracture that is actively recruiting participants, run by Columbia University. The registered enrollment target is 270 participants, above the 234-participant average among 4 other Glomerular Disease trials with a reported enrollment target (15% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04528446, a study of Glomerular Disease and Bone Fracture, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 270 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objectives of this study are to: (1) determine the impact of glomerular disease on bone strength and (2) investigate the pathophysiologic underpinnings of impaired bone strength in glomerular disease.
Conditions Studied
Interventions
- OTHER Questionnaires
- RADIATION Dual-energy X-ray absorptiometry
- RADIATION High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT)
- OTHER Blood draw and Urine collection
Study Locations (2)
New York
- Columbia University Irving Medical Center - New York
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2024-12 |
What NCT04528446 shows while recruiting
NCT04528446 is an observational study that tracks outcomes without assigning an intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, above the 234-participant average among 4 other Glomerular Disease trials with a reported enrollment target (15% higher).
The record links to 3 conditions, with Glomerular Disease appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.
NCT04528446 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04528446 about?
NCT04528446 is a clinical study titled "The Impact of Glomerular Disorders on Bone Quality and Strength". The primary objectives of this study are to: (1) determine the impact of glomerular disease on bone strength and (2) investigate the pathophysiologic underpinnings of impaired bone strength in glomerular disease.
What is the current status of trial NCT04528446?
This trial is currently recruiting. The enrollment target is 270 participants. The study started on 2019-06-14. Estimated completion is 2024-12.
What conditions does trial NCT04528446 study?
This clinical trial studies the following conditions: Glomerular Disease, Bone Fracture, Bone Diseases, Metabolic.
What interventions are being tested in trial NCT04528446?
The interventions under investigation include: Questionnaires (OTHER), Dual-energy X-ray absorptiometry (RADIATION), High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) (RADIATION), Blood draw and Urine collection (OTHER).
Who is sponsoring clinical trial NCT04528446?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04528446 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glomerular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RECRUITING · Phase 2
-
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
RECRUITING
-
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RECRUITING · Phase 3
-
Pathogenesis of Glomerulosclerosis
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
- NCT05362292 · 270 participants · Phase 4
TReating Incontinence for Underlying Mental and Physical Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI